Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Санкт-Петербургский государственный медицинский университет им. И.П.Павлова
Список исп. литературыСкрыть список 1. Grippo AJ, Johnson AK. Biological mechanisms in the relationship between depression and heart diseases. Neuroscience & Biobehavioral Reviews. 2002; 26 (issue 8): 941–62. 2. Anda R, Williamson D et al. Depressed affect, hopelessness and the risk of ischemic heart diseases in a cohort of US adults. J Epidemiology 1993; 4: 285–294. 3. Barefoot JC, Helms MJ et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78: 613–7. 4. Carney RM, Rich MW et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Circulation 1995; 91: 999–1005. 5. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Circulation 1995; 91: 999–1005. 7. Spertus JA, McDonell M et al. Association between depression and worse disease-specific functional status in out patients with coronary artery diseases. Am Heart J 2000; 140: 105–110. 8. Williams SA, Kasl SV et al. Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med 2002; 64: 6–12. 9. Palazidou E. Фармакотерапия тревожной депрессии. Дондон, 2000. 10. Kessler RC, McGonagle KA et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey (NCS). Arch Gen Psychiat 51: 8–19. 11. Anda RF, Williamson DF et al. Depression and the dynamics of smoking. A national perspective. JAMA 1990; 264: 1541–5. 12. Arijo AA, Haan M et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Colloborative Research Group. Circulation 2000; 102: 1773–9. 13. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction and total mortality in a community sample. Circulation 1996; 93: 1976–80. 14. Ford DE, Mead LA. Depression is a risk factor for coronary artery disease in men: The precursor study. Arch Intern Med 1998; 158: 1422–6. 15. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impacton 6-month survival. JAMA 1993; 270: 1819–25. 16. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: Epidemyology, biology and treatment. Arch Gen Psychiatry 1998; 55: 580–92. 17. Rosanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192–217. 18. O\'Connor CM, Gurbell PA, Serebruany VL. Depression and ischemic heart disease. Am Heart J 2000; 140: 63–9. 19. Smith TW, Ruiz JM. Psychosocial influences on the development and course of coronary heart disease: current status and implications for research and practice. J Consult Clin Psychol 2002; 70: 548–68. 20. Januzzi JL, Stern TA et al. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000; 160: 1913–21. 21. Carney RM, Rich MW et al. Major depressive disorder in coronary artery disease. Am J Cardiol 1987; 60: 1273–5. 22. Carney RM, Freedland KE et al. Depression and coronary heart disease: a review for cardiologists. Clin Cardiol 1997; 20: 196–200. 23. Bliven BD, Creen CP, Spertus JA. Review of available instruments and methods for assessing quality of life in anti-anginal trials. Drugs Aging 1998; 13: 311–20. 24. Frasure-Smith N, Lesperance F et al. Gender, depression and one-year prognosis after myocardial infarction. Psychosom Med 1999; 61: 26–37. 25. Wang PS, Bohn RL et al. Non compliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002; 17: 504–11. 26. Horwitz RI, Viscoli CM et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336: 542–5. 27. Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993; 270: 742–4. 28. Ziegelstein RC, Bush DE, Fauerbach JA. Depression, adherence behavior and coronary disease outcome. Arch Intern Med 1998; 158: 808–9. 29. Breslau N, Peterson EL. Major depression and stages of smoking: A longitudinal investigation/Arch Gen Psychiatry 1998; 55: 161–6. 30. Horsten M, Wamala SP et al. Depressive symptoms, social support and lipid profile in healthy middle-aged women. Psychosom Med 1997; 59: 521–8. 31. Hyyppa MT, Kronholm E et al. Does simvaststin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial. Psychneuroendocrinology 2003; 28: 181–94. 32. Olusi SO, Fido AA. Serum lipid concentrations in patients with mayor depressive disorder/Biol Psychiatry 1996; 40: 1128–31. 33. Steegmans PH, Fekkes D et al. Low serum cholesterol concentration and serotonin metabolism in men. BMJ 1996; 312: 221. 34. Steegmans PH, Hoes AW et al. Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels. Psychosom Med 2000; 62: 205–11. 35. Homocystein Studies Collaboration. Homocystein and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002; 288: 2015–22. 36. Severus WS, Littman AB, Stoll AL. Omega-3 fatty acids homocysteine and the increased risk of cardiovascular mortality in mayor depressive disorder. Harv Rev Psychiat 2001; 9: 280–93. 37. Tolmunen T, Hintikka J et al. Association between depressive symptoms and serum concentrations of homocysteine in men: a population study. Am J Clin Nutr 2004, 80 (6): 1574–8. 38. Bjelland I, Tell GS et al. Folate, vitamin B12, homocysteine and the MTMFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003; 60 (6): 618–26. 39. Guaraldi GP, Fava M et al. An open trial of methyltetrahydrofblate in elderly depressed patients. Ann Clin Psychiat 1993; 5: 101–5. 40. Joynt KE, Whellan DJ, O\'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biological Psychiat 2003; 54 (Issue 3): 248–61. 41. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary – adrenal axis. Psychiatr Clin North Am 1998; 21: 293–307. 42. Gold PW, Gabry KE et al. Divergent endocrine abnormalities in melancholic and atypical depression: Clinical and pathophsiologic implications. Endocrinol Metab Clin North Am 2000; 31: 37–62. 43. Remme WJ. The sympathetic nervous system and ischaemic heart disease. Eur Heart J 1998; 19 (Suppl. F): F62–F71.